Boston Scientific (BSX) News
What's actually happening: chronological and provenance-stamped. News is context, not a signal.
The percentage on each card is BSX's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

NEW YORK, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX). Such investors are advised t…

AlTi Global Inc. decreased its position in Boston Scientific Corporation (NYSE: BSX) by 76.0% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 5,109 shares of …

Boston Scientific BSX saw modest sales growth in the third quarter, with revenues climbing 1.5% year over year to $5.14 billion, though its adjusted earnings per share (“EPS”) dipped 2.7% to 73 cents year over year. Prim…

Aberdeen Group plc increased its position in shares of Boston Scientific Corporation (NYSE: BSX) by 3.5% during a recent quarter, according to its most recent filing with the Securities and Exchange Commission. The insti…

Boston Scientific (NYSE: BSX) executives said they expect durable growth across the company's interventional portfolio, while acknowledging that its pulsed field ablation and WATCHMAN businesses face competitive challeng…

I last wrote about Boston Scientific ( BSX ) as the Bear of the Day in early August after their Q2 report and management's lowered guidance propelled analysts to notch down their EPS estimates for this year and next, cau…

Allspring Global Investments Holdings LLC cut its position in shares of Boston Scientific Corporation (NYSE: BSX) by 11.4% in a recent quarter, according to its most recent disclosure with the Securities and Exchange Com…

BSX bets on WATCHMAN growth through clinical trials and physician outreach, even as slowing demand and rising competition cloud its outlook.…

NEW YORK, Nov. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX). Such investors are advised to co…

AMG National Trust Bank bought a new stake in shares of Boston Scientific Corporation (NYSE: BSX) during a recent quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institut…

Boston Scientific Corporation (BSX) Presents at Stifel 2026 Healthcare Conference 2026 Transcript…

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) ana…

Ethic Inc. boosted its position in Boston Scientific Corporation (NYSE: BSX) by 11.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institut…

NEW YORK--(BUSINESS WIRE)---- $BSX #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Boston Scientific Corporation (NYSE: BSX) failed to manage Bo…

Boston Scientific (BSX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.…

Boston Scientific's cyber disruption cuts Q3 growth and earnings, forcing lower 2026 guidance as management sees 2027 as the cycle's trough.…

Boston Scientific's steep valuation discount faces a major test as earnings estimates weaken, core franchises lose momentum and key growth catalysts shift to 2028.…

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Blackstone Life Sciences (“BXLS”) today announced a $455 million collaboration with Boston Scientific Corporation (NYSE: BSX) to co-fund the development of the VITALYST™ Temporary Percu…

Both post-implant monotherapies in the trial achieved non-inferiority compared to dual anti-platelet therapy (DAPT) supporting the potential to simplify post-procedure drug regimens MARLBOROUGH, Mass. and SAN DIEGO, Nov.…

Intuitive Surgical's surging robotic surgery demand and stronger earnings momentum make it a better buy than Boston Scientific despite its valuation premium.…

Pre-Market Stock Futures: Futures are trading lower this Friday, with the Nasdaq down almost 2.…

BSX, NBHC and NMRK have been added to the Zacks Rank #5 (Strong Sell) List on October 30th, 2026.…

MARLBOROUGH, Mass., Oct. 28, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.138 billion during the third quarter of 2026, growing 1.5 percent on a reported, operational1 and orga…

MARLBOROUGH, Mass., Oct. 26, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Stifel's 2026 Healthcare Conference on Wednesday, November 11, 2026.…

NEW YORK--(BUSINESS WIRE)---- $BSX #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Boston Scientific Corporation (NYSE: BSX) failed to manage Bo…
Kept in their own lane. A press release is the company talking, not reporting.
Expected by Feb 3. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

